register

News & Trends - MedTech & Diagnostics

Medtronic VP urges essential funding and policy shifts to fully unlock AI potential: Reimagining Healthcare senior leadership series

Health Industry Hub | August 8, 2024 |

MedTech & Diagnostics News: In the latest interview for the Reimagining Healthcare senior leadership series, Liz Carnabuci, Vice President and Managing Director of Medtronic ANZ & Vice President, Diabetes Group APAC, delved into the transformative potential of digital health and artificial intelligence (AI) in shaping the future of healthcare in Australia.

“The vision when we think about AI and digital technologies, is this real connectedness for the patient, clinician, and our healthcare system,” she said.

Carnabuci emphasised that while the pandemic accelerated technological adoption, a cultural shift towards fully embracing digital health and AI remains a significant hurdle.

“The different systems, the different infrastructures that don’t really speak to each other – we really need to address these items. Another key part is around privacy…and that’s quite a significant piece,” she emphasised.

“The financial restraint and reimbursement gap to achieving that universal integration are quite significant too,” she added.

The rise of AI, exemplified by tools like ChatGPT, has captured the public’s imagination, but Carnabuci cautioned that its application in healthcare must be underpinned by robust evidence of efficacy, safety and privacy to “help us enhance accuracy, efficiencies and more importantly personalised patient outcomes”.

Addressing the role of governments and regulatory bodies, Carnabuci called for a more “harmonised” approach to regulation that keeps pace with the rapid advancements in digital health and AI. She stressed the need for evolving policies that can accommodate and guide the integration of these technologies into healthcare systems without stifling innovation.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Australians face lengthy delays for PBS and Medicare claims

Australians face lengthy delays for PBS and Medicare claims: Has Labor brought Services Australia to its knees?

Health Industry Hub | January 20, 2025 |

Wait times for health services through Services Australia have skyrocketed under the Labor Government, with Australians now enduring nearly three […]

More


News & Trends - Pharmaceuticals

Commission proposes major overhaul of obesity diagnosis

Commission proposes major overhaul of obesity diagnosis

Health Industry Hub | January 20, 2025 |

A global Commission, endorsed by 76 organisations – including Australian scientific societies and patient advocacy groups – has introduced a […]

More


News & Trends - MedTech & Diagnostics

Department of Health scraps Prescribed List reform measures amid stakeholder backlash

Department of Health scraps Prescribed List reform measures amid stakeholder backlash

Health Industry Hub | January 20, 2025 |

The Department of Health has declared “insufficient evidence” to justify legislating two proposed measures related to the Prescribed List (PL) […]

More


Leadership & Management

Boehringer Ingelheim rolls out the red carpet for Hollywood

Boehringer Ingelheim rolls out the red carpet for Hollywood

Health Industry Hub | January 20, 2025 |

Boehringer Ingelheim has appointed a new General Manager for its Australia and New Zealand (ANZ) operations, with Ed Hollywood set […]

More


This content is copyright protected. Please subscribe to gain access.